Canada· CA-DIN-02243676
RECOMBIVAX HB
A hepatitis b, gereinigtes antigen product containing hepatitis b surface antigen (recombinant), registered in Canada by MERCK CANADA INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Hepatitis b, gereinigtes antigen is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC01 (hepatitis b, gereinigtes antigen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Hepatitis b, gereinigtes antigen · ATC J07BC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)
- Manufacturer
- MERCK CANADA INC
- Country
- Canada (CA)
- ATC code
- J07BC01
- ATC class
- Hepatitis B, gereinigtes Antigen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
255 interactions on record for hepatitis b, gereinigtes antigen.
Graded by severity as the source publishes them — 255 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hepatitis b, gereinigtes antigen · interactions on record
255 records
- 255 moderate
Most severe, free to view
- PrednisoloneA07EA01moderate
- HydrocortisoneA07EA02moderate
- PrednisoneA07EA03moderate
- BetamethasoneA07EA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hepatitis b, gereinigtes antigen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENGERIX-BGlaxoSmithKline Biologicals S.A., Rixensart
- BelgiumAmbirixGlaxoSmithKline Biologicals
- IrelandFendrix suspension for injectionGlaxoSmithKline Biologicals S.A.
- NetherlandsEngerix-B 20 microgram/1 ml, suspensie voor injectieEuro Registratie Collectief B.V.
- United KingdomEngerix B 10micrograms/0.5ml vaccine suspension for injection pre-filled syringesGlaxoSmithKline UK Ltd
- SpainENGERIX- B 20 microgramos/1 ml, SUSPENSIÓN INYECTABLEGlaxosmithkline S.A.
- PolandEngerix BGlaxoSmithKline Biologicals S.A.
- Japan組換え沈降Ｂ型肝炎ワクチン（チャイニーズハムスター卵巣細胞由来）
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fec36bd9-245d-448e-b6ab-7d2119fa0ddf GET /v1/drugs/fec36bd9-245d-448e-b6ab-7d2119fa0ddf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02243676",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07BC01",
"schedule": [
"Schedule D"
],
"drug_code": "67606",
"strengths": [
"10 MCG"
],
"ahfs_class": null,
"substances": [
"HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)"
],
"product_categorization": null
}See everything about hepatitis b, gereinigtes antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.